February 14, 2024Journal of Clinical MedicineOpen Access

Morbidity among Adolescent Hypnotic Drug Users in Norway: An Observational Population-Based Study

View Full Paper

Ask AI

Bookmark

Mental and behavioral disorders represent the primary morbidity among adolescent hypnotic drug users, while specific sleep disorder diagnoses remain rare.
Over 77% of boys and 82% of girls initiating hypnotic drugs were referred to specialist care, where psychiatric conditions accounted for roughly half of diagnoses.
Analysis of registry records across Norway tracked 13–17-year-old individuals, highlighting that adolescent hypnotic drug use signals severe psychiatric distress.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Cohort study reveals high rates of psychiatric morbidity among adolescent hypnotic drug users, indicating that sleep medication initiation reflects substantial mental health burdens.

Cite This Study

Sharikabad et al. (2024) studied this question.

synapsesocial.com/papers/68e7940ab6db643587704e3e https://doi.org/10.3390/jcm13041075

View Full Paper

Ask AI

Bookmark

Implication

Cohort study reveals high rates of psychiatric morbidity among adolescent hypnotic drug users, indicating that sleep medication initiation reflects substantial mental health burdens.

Morbidity among Adolescent Hypnotic Drug Users in Norway: An Observational Population-Based Study

Key Points

Discussion

Implication

Cite This Study

Morbidity among Adolescent Hypnotic Drug Users in Norway: An Observational Population-Based Study

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider